
ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us and our hands-on approach to production and development that sets us apart. If you are looking for a dynamic, innovative, growing company in the biopharmaceutical industry that is committed to excellence and integrity, then consider ADMA Biologics. We currently have an exciting opportunity available for a Physician Substitute - LPN, RN, Paramedic or EMT-A in Dallas, GA!
Under the direction of the Medical Director and/or Center Licensed Physician(s), the Physician Substitute determines the acceptability of all first-time donors and return applicant donors. The Physician Substitute determines the suitability of donors by following Standard Operating Procedures (SOPs) designed to ensure the donor meets suitability criteria in accordance with FDA guidance and regulations. The Physician Substitute also reviews normal donor laboratory test and refers abnormal test to the Physician for review.
The Physician Substitute works closely with the Medical Director or Licensed Center Physician(s) while making any decisions which directly impact donor suitability. The Physician Substitute also provides medical oversight in screening, phlebotomy, and the plasma processing areas.
Ability to follow the cGMP’s and procedures with great attention to detail
Able to work in high-pressure, deadline-driven environment
Basic computer skills including experience with software programs such as Word, Excel, and GroupWise
Demonstrated ability to achieve goals, overcome obstacles, and meet deadlines
Demonstrated ability to work well with people from diverse backgrounds
Maintains a professional appearance and demeanor when interacting with peers and donors
As a part of our Quality Systems and cGMP initiatives, employees are responsible for ensuring compliance with all ADMA Quality policies, standards, and SOPs in their area of work and responsibility. This includes ensuring all Quality Assurance (QA) records and reports, Human Resources (HR) policies, and Environmental Health and Safety (EH&S) procedures and practices are completed in a timely manner. Any delay or failure to comply with policies, standards and procedures is required to be communicated/escalated to the appropriate responsible parties, such as QA, HR, or EH&S depending on the issue.
The Physician Substitute may not:
-Therapeutic Exchange Plasma
-RBC Immunization
-Plasmapheresis of HBsAg reactive Donors
-Plasmapheresis of HIV antibody positive Donors
-Disease State Donor Programs
In addition to competitive compensation, we offer a comprehensive benefits package including:
ADMA Biologics uses E-Verify to confirm the employment eligibility of all newly hired employees. To learn more about E-Verify, including your rights and responsibilities, please visit www.dhs.gov/E-Verify.

ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com.